Table 2 Summary of HR for OS by Age
From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Age | HR (95% CI) |
|---|---|
Age < 65 years | 0.68 (0.61 to 0.75) |
Age ≥ 65 years | 0.64 (0.54 to 0.76) |
From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Age | HR (95% CI) |
|---|---|
Age < 65 years | 0.68 (0.61 to 0.75) |
Age ≥ 65 years | 0.64 (0.54 to 0.76) |